This test is most useful if any of these apply to you.
If you feel chronically fatigued, struggle with mood, or want to understand how well your body is fueling its own repair systems, your blood vitamin B3 level offers a window most standard panels ignore entirely. Vitamin B3 is not part of a routine metabolic panel or CBC. You will never see it flagged unless you specifically order it.
What makes this test interesting is what vitamin B3 feeds into. Once absorbed, your cells convert it into NAD (nicotinamide adenine dinucleotide), a molecule central to how your body generates energy, fixes damaged DNA, and keeps neurons alive. Blood vitamin B3 is still an emerging measurement without universally agreed-upon clinical cutpoints, but it can offer early insight into whether your cells have the raw material they need to keep those systems running.
Vitamin B3 (niacin) is a small organic molecule, not a protein or hormone. It comes in two main forms: nicotinic acid and nicotinamide. Both are absorbed from food and converted inside your cells into NAD and NADP, two helper molecules that participate in hundreds of chemical reactions. NAD drives the energy-producing pathways in your cells, while NADP supports your body's internal cleanup and repair systems.
Humans cannot make enough vitamin B3 on their own. You get it primarily from diet, with meat, fish, grains, and dairy being the richest sources. Your body can also make a small amount from the amino acid tryptophan, which is found in protein-rich foods. Because virtually every cell in your body converts B3 into NAD, there is no single organ that "produces" this vitamin. It is a whole-body nutrient.
One of the most clinically striking findings about blood vitamin B3 comes from research on depression. In a study comparing 94 medicated patients with depression to 57 age- and sex-matched healthy controls, plasma nicotinamide concentrations were significantly lower in the depressed group, with a moderate to large effect size. A breakdown product of nicotinamide, called N1-methylnicotinamide, was also reduced.
This matters because NAD, the molecule your body makes from vitamin B3, is essential for neuronal development and survival. When NAD levels drop, neurons become more vulnerable to cellular wear from unstable molecules and energy failure, processes that contribute to both mood disorders and conditions that progressively damage brain cells, like Alzheimer's and Parkinson's disease. A low blood B3 reading in someone with unexplained fatigue, cognitive fog, or depressive symptoms could point toward a nutritional gap that standard labs would miss.
Glaucoma, a progressive disease that damages the nerve cells at the back of the eye, has also been linked to low serum nicotinamide. A randomized clinical trial of 57 glaucoma patients, where each participant received both nicotinamide and placebo in sequence, found that nicotinamide supplementation (starting at 1.5 grams per day and increasing to 3 grams per day) improved inner retinal function by about 15% over twelve weeks. Visual field sensitivity also showed a trend toward improvement, with 27% of participants gaining at least 1 decibel on nicotinamide versus fewer on placebo.
The connection is metabolic: the retinal ganglion cells affected by glaucoma are under enormous energy stress, and NAD is the fuel that keeps their repair systems running. When serum nicotinamide is low, those cells may not be getting enough raw material to maintain themselves.
While the evidence linking measured blood vitamin B3 to hard outcomes is still emerging, several large population studies have examined dietary niacin intake and mortality risk. These are not direct evidence about what your blood test result means, but they provide important context about why niacin status matters.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 26,746 US adults, median follow-up 9.2 years | Highest vs lowest quartile of dietary niacin intake | About 26% lower risk of all-cause death and 27% lower risk of cardiovascular death |
| 4,377 adults with existing cardiovascular disease | Highest vs lowest quartile of dietary niacin intake | About 26% lower risk of all-cause death and 33% lower risk of cardiovascular death |
| 8,744 adults with metabolic syndrome, median follow-up about 9 years | Highest vs lowest quartile of dietary niacin intake | About 32% lower risk of all-cause death and 37% lower risk of cardiovascular death |
Sources: Lin et al. 2024 (NHANES 2003 to 2018); Yang et al. 2024 (NHANES 2003 to 2018); Fu et al. 2024 (NHANES).
These dietary intake studies consistently show that people who consume more niacin from food have lower risks of dying from cardiovascular disease and from all causes. The association held after adjusting for standard risk factors including age, sex, BMI, smoking, and other nutrient intake. A dose-response relationship was also observed, meaning the benefit grew with higher niacin consumption. However, these studies measured what people ate, not what was circulating in their blood. Whether blood vitamin B3 levels track the same pattern is plausible but not yet confirmed with the same rigor.
You might expect that low blood B3 is always the problem, but a study of 57 healthy and 57 obese Emirati adults found that plasma nicotinamide was actually significantly higher in the obese group. This could reflect altered vitamin B3 metabolism in obesity, where the body may be mobilizing more nicotinamide but using it less efficiently.
This finding illustrates an important principle: for blood vitamin B3, the number alone does not tell the whole story. A high reading does not automatically mean you are in good shape, and the relationship between blood levels and cellular function is not always straightforward. Context matters, and so does the trend over time.
A study of 1,518 community-dwelling adults measured whole blood NAD levels (a related but different measurement from blood B3) across age groups. The average whole blood NAD concentration was 33.0 micromoles per liter. NAD declined with aging, but this decline was significant mainly in men, particularly between ages 40 and 49. Women did not show the same pattern. Interestingly, research on the broader NAD metabolome in plasma found that while NAD itself decreases with age, nicotinamide (the form most likely captured by a blood B3 test) may actually increase.
This apparent paradox likely reflects the body's attempt to compensate for declining NAD by releasing more of the precursor into the bloodstream. Think of it like a factory ramping up raw material shipments because the assembly line is slowing down. The raw material (nicotinamide) goes up, but the finished product (NAD) goes down. This is why blood B3 should be interpreted alongside other markers, not in isolation.
Blood vitamin B3 does not have consensus clinical reference ranges the way cholesterol or blood sugar does. This is a Tier 3 research marker, and standardized cutpoints do not yet exist. The values your lab reports will depend heavily on the testing method used and whether the test measures nicotinamide, nicotinic acid, or both.
In the study of Emirati adults using a highly sensitive lab method (HPLC tandem mass spectrometry), healthy volunteers had measurably different plasma nicotinamide concentrations than those reported in Western populations. This shows that population, ethnicity, diet, and lab method all affect what "normal" looks like for this measurement. Your best strategy is to establish your own baseline and track changes from there.
Several factors can distort a single blood vitamin B3 reading:
Because blood vitamin B3 lacks universal reference ranges, a single result is most useful as a starting point. Where this test adds real value is in tracking your number over time under consistent conditions: same lab, same fasting status, same time of day, and consistent supplement and medication use between draws.
For B vitamins in general, research on biological variation shows that the change within the same person from day to day can range from about 5% to 38%, depending on the specific vitamin. Reference change values (the minimum change needed to be confident a real shift has occurred, not just normal fluctuation) can be as high as 50% to 100% for some vitamins. This means that small changes between two tests may be noise, and you should look for consistent directional movement across at least two to three measurements before concluding anything meaningful.
Get a baseline now. If you make dietary changes or start a B3-related supplement, retest in 8 to 12 weeks. After that, annual monitoring is reasonable for most people. If you are tracking a specific concern like mood, fatigue, or a glaucoma diagnosis, more frequent testing every 3 to 6 months can help you see whether your intervention is actually moving the number.
If your blood vitamin B3 comes back low, the most common explanations are dietary insufficiency, chronic alcohol use (which depletes B3 stores and impairs absorption), or malabsorption conditions. The first step is to retest under standardized conditions (fasting, no supplements for 48 hours if safe to pause them, stable health) to confirm the finding.
A confirmed low result alongside symptoms like fatigue, mood changes, or skin issues should prompt a broader B vitamin workup, including B12, folate, and homocysteine. If you have glaucoma or a family history of glaucoma, a low B3 result adds urgency to discussing nicotinamide supplementation with an eye specialist. If your result is unexpectedly high and you are not supplementing, consider whether kidney function, obesity-related metabolic changes, or recent dietary patterns could be driving it. An eGFR (estimated glomerular filtration rate) test can help rule out kidney clearance issues.
Because this is still an exploratory marker, a single reading should not drive major clinical decisions on its own. It is most powerful when combined with related tests and interpreted in the context of your symptoms, diet, and health history.
Evidence-backed interventions that affect your Vitamin B3 level
Vitamin B3 is best interpreted alongside these tests.